Industry
In a newly published study Probi´s proprietary strain L. plantarum HEAL9 (HEAL9™) was shown to significantly improve cognitive performance.
Industry
A new study asserts resB® Lung Support improves lung function through microbiome-mediated mechanisms along the gut-lung axis in asthmatic population
A new study demonstrated that daily intake of Probi's proprietary strain Lacticaseibacillus paracasei 8700:2 significantly reduced cardiovascular disease risk.
Industry
With all aspects of LBPs covered in the summit, the 8th Microbiome Movement Summit in Boston became the hub for sharing the latest insights in LBP research and development.
Industry
Ongoing Phase 3 trial built on positive data from Phase 2 HERACLES study and ongoing early access program (EAP) in France: both datasets showed that MaaT013 was well-tolerated in immunocompromised…
The microbiological laboratory applying AI to specific analysis activities.
Industry
Topical treatment is achieving all endpoints for efficacy and safety in mild, moderate, and severe atopic dermatitis.
Industry
The collaboration will focus on various aspects of the human microbiome that could benefit new product development.
Industry
The FDA has granted orphan drug designation for IBT’s product IBP-1016 for gastroschisis.
Industry
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x.